Making gene therapy for osteosarcoma a reality

QR Code

Making gene therapy for osteosarcoma a reality

Bibliographic Details
Main Authors:	Broadhead, M., Clark, J., Choong, P., Dass, Crispin
Format:	Journal Article
Published:	Expert Reviews Ltd. 2010
Online Access:	http://hdl.handle.net/20.500.11937/21808

Similar Items

The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)

Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)

Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)

Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)

RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)

RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)

Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)

Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)

The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010)

The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)

Nanoparticle-Mediated Interleukin-12 Cancer Gene Therapy
by: Hallaj-Nezhadi, S., et al.
Published: (2010)

Intraperitoneal delivery of nanoparticles for cancer gene therapy
by: Hallaj-Nezhadi, Somayeh, et al.
Published: (2013)

Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)

Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)

Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy
by: Hallaj-Nezhadi, S., et al.
Published: (2010)

Canine osteosarcoma: a relevant comparative model for osteosarcoma in man
by: Selvarajah, Gayathri Thevi
Published: (2011)

Reference gene validation for gene expression normalization in canine osteosarcoma: a geNorm algorithm approach
by: Selvarajah, Gayathri Thevi, et al.
Published: (2017)

Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)

Elucidation Of DNA Damage Response Pathways And Functional Efficiency Of DNA Repair Genes Associated With Reprogrammed Osteosarcoma Cell Lines
by: Choong, Pei Feng
Published: (2018)

Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)

New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
by: Clark, J., et al.
Published: (2010)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
by: Baxter-Holland, M., et al.
Published: (2018)

An Evolutionary Variable Neighborhood Search for Selecting Combinational Gene Signatures in Predicting Chemo-Response of Osteosarcoma
by: Chan, Kit Yan, et al.
Published: (2010)

Current research on pharmacologic and regenerative therapies for osteoarthritis
by: Zhang, W., et al.
Published: (2016)

Dz13, a c-jun DNAzyme, Is a Potent Inducer of Caspase-2 Activation
by: Dass, Crispin, et al.
Published: (2010)

Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls
by: Poon, B., et al.
Published: (2016)

Primary aggressive osteosarcoma of sphenoid bone
by: Che Jalil, Nur Asyilla, et al.
Published: (2023)

Primary aggressive osteosarcoma of sphenoid bone
by: Che Jalil, Nur Asyilla, et al.
Published: (2022)

Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)

Barriers to liposomal gene delivery: From application site to the target
by: Saffari, M., et al.
Published: (2016)

Primary pulmonary osteosarcoma in a dog with associated hypertrophic osteopathy
by: Seiler, R. J.
Published: (1979)

Transdifferentiation of myoblasts into osteoblasts - possible use for bone therapy
by: Lin, Daphne, et al.
Published: (2017)

Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
by: Tan, M., et al.
Published: (2010)

Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)

Pigment Epithelium-Derived Factor as an Impending Therapeutic Agent Against Vascular Epithelial Growth Factor-Driven Tumor-Angiogenesis
by: Manalo, K., et al.
Published: (2011)

Osteosarcoma: overview, case discussion & Islamic perspective of treatment
by: Sharifudin, Mohd Ariff
Published: (2014)

Osteosarcoma in neonate with rare liver metastasis and abdominal lymphadenopathy
by: Mohamad Sani, Suraini, et al.
Published: (2018)

Evaluation of prognostic factors in patients with osteosarcoma: the HUSM experience
by: Mohd Sofian, Azlan
Published: (2015)

The incidence of malignant infiltration in human osteosarcoma biopsy tract
by: Roa, Mohana
Published: (2006)

Cannot write session to /tmp/vufind_sessions/sess_f72nmoulie4so12fp2hajf5243